Is AKH undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
2/6
Valuation Score 2/6
Below Fair Value
Significantly Below Fair Value
Price-To-Sales vs Peers
Price-To-Sales vs Industry
Price-To-Sales vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of AKH when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: Insufficient data to calculate AKH's fair value for valuation analysis.
Significantly Below Fair Value: Insufficient data to calculate AKH's fair value for valuation analysis.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for AKH?
Key metric: As AKH is unprofitable we use its Price-To-Sales Ratio for relative valuation analysis.
The above table shows the Price to Sales ratio for AKH. This is calculated by dividing AKH's market cap by their current
revenue.
What is AKH's PS Ratio?
PS Ratio
0.3x
Sales
NOK 3.90b
Market Cap
NOK 1.23b
AKH key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Price-To-Sales vs Industry: AKH is good value based on its Price-To-Sales Ratio (0.3x) compared to the European Commercial Services industry average (0.6x).
Price to Sales Ratio vs Fair Ratio
What is AKH's PS Ratio
compared to its
Fair PS Ratio?
This is the expected PS Ratio taking into
account the company's forecast earnings growth, profit margins
and other risk factors.
AKH PS Ratio vs Fair Ratio.
Fair Ratio
Current PS Ratio
0.3x
Fair PS Ratio
n/a
Price-To-Sales vs Fair Ratio: Insufficient data to calculate AKH's Price-To-Sales Fair Ratio for valuation analysis.
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
The above table shows the analyst AKH forecast and predictions for the stock price in 12 month’s time.
Date
Share Price
Average 1Y Price Target
Dispersion
High
Low
1Y Actual price
Analysts
Current
NOK 1.78
NOK 6.50
+265.0%
69.2%
NOK 11.00
NOK 2.00
n/a
2
Nov ’25
NOK 2.32
NOK 14.73
+535.6%
76.4%
NOK 30.00
NOK 3.20
n/a
3
Oct ’25
NOK 2.66
NOK 14.73
+453.9%
76.4%
NOK 30.00
NOK 3.20
n/a
3
Sep ’25
NOK 2.41
NOK 14.73
+511.8%
76.4%
NOK 30.00
NOK 3.20
n/a
3
Aug ’25
NOK 2.70
NOK 14.73
+446.5%
76.4%
NOK 30.00
NOK 3.20
n/a
3
Jul ’25
NOK 2.82
NOK 14.80
+424.5%
75.6%
NOK 30.00
NOK 3.40
n/a
3
Jun ’25
NOK 3.04
NOK 14.80
+386.8%
75.6%
NOK 30.00
NOK 3.40
n/a
3
May ’25
NOK 2.85
NOK 15.13
+431.7%
71.7%
NOK 30.00
NOK 4.40
n/a
3
Apr ’25
NOK 3.10
NOK 15.13
+388.2%
71.7%
NOK 30.00
NOK 4.40
n/a
3
Mar ’25
NOK 3.83
NOK 15.13
+295.5%
71.7%
NOK 30.00
NOK 4.40
n/a
3
Feb ’25
NOK 4.64
NOK 15.23
+228.6%
70.6%
NOK 30.00
NOK 4.70
n/a
3
Jan ’25
NOK 4.36
NOK 13.93
+219.7%
68.8%
NOK 30.00
NOK 4.70
n/a
4
Dec ’24
NOK 4.13
NOK 13.93
+237.2%
68.8%
NOK 30.00
NOK 4.70
n/a
4
Nov ’24
NOK 3.37
NOK 14.30
+324.3%
64.6%
NOK 30.00
NOK 6.20
NOK 2.32
4
Oct ’24
NOK 4.59
NOK 14.30
+211.5%
64.6%
NOK 30.00
NOK 6.20
NOK 2.66
4
Sep ’24
NOK 4.64
NOK 14.30
+208.3%
64.6%
NOK 30.00
NOK 6.20
NOK 2.41
4
Aug ’24
NOK 5.70
NOK 14.30
+150.9%
64.6%
NOK 30.00
NOK 6.20
NOK 2.70
4
Jul ’24
NOK 6.79
NOK 19.00
+179.8%
41.4%
NOK 30.00
NOK 12.00
NOK 2.82
3
Jun ’24
NOK 7.36
NOK 19.00
+158.2%
41.4%
NOK 30.00
NOK 12.00
NOK 3.04
3
May ’24
NOK 8.39
NOK 26.67
+217.8%
9.4%
NOK 30.00
NOK 24.00
NOK 2.85
3
Apr ’24
NOK 9.31
NOK 26.67
+186.4%
9.4%
NOK 30.00
NOK 24.00
NOK 3.10
3
Mar ’24
NOK 11.67
NOK 26.67
+128.5%
9.4%
NOK 30.00
NOK 24.00
NOK 3.83
3
Feb ’24
NOK 15.30
NOK 29.67
+93.9%
4.2%
NOK 31.00
NOK 28.00
NOK 4.64
3
Jan ’24
NOK 12.90
NOK 29.67
+130.1%
4.2%
NOK 31.00
NOK 28.00
NOK 4.36
3
Dec ’23
NOK 12.70
NOK 29.75
+134.3%
3.7%
NOK 31.00
NOK 28.00
NOK 4.13
4
Nov ’23
NOK 14.13
NOK 30.38
+115.0%
3.2%
NOK 32.00
NOK 29.50
NOK 3.37
4
Analyst Forecast: Target price is more than 20% higher than the current share price, but there are not enough analysts covering the stock to determine statistical confidence in agreement.